Firms operating in shock-prone emerging economies require more than financial reserves. They must be able to recognize changes in financing conditions, mobilize liquidity, reconfigure funding and asset use, preserve economically valuable investment, and rebuild depleted buffers after disruption. This article develops financial adaptability as a distinct capability-based construct and separates it from financial flexibility, financial slack, financial resilience, and broader organizational resilience. It uses an integrative conceptual synthesis of 20 verified studies spanning the resource-based view, dynamic capabilities, organizational resilience, corporate liquidity, financial constraints, crisis transmission, and commodity dependence. The proposed framework treats financial adaptability as a cycle comprising financial anticipation, liquidity absorption, financing reconfiguration, asset-use reconfiguration, profit and cost adjustment, investment preservation, and financial recovery and renewal. Eight theoretical propositions explain why adaptability should become more valuable under adverse macroeconomic conditions, when firms face financing constraints, and in commodity-dependent environments exposed to correlated price, exchange-rate, interest-rate, and credit shocks. The article further proposes observable indicators and a research agenda for construct validation, dynamic measurement, causal identification, nonlinear effects, and cross-country testing. The central argument is that financial flexibility represents available room for manoeuvre, whereas financial adaptability captures the capability to deploy, reconfigure, and replenish that room in a timely and disciplined manner. This distinction provides a foundation for future empirical work without treating any single financial ratio or static index as a complete measure of adaptive capacity.

Acute infectious diseases represent a persistent public health burden that exerts sustained pressure on hospital bed capacity, treatment resources, and the allocation of the healthcare workforce. Strengthening hospital-level preparedness and resource planning requires reliable early-risk stratification tools that remain robust to real-world temporal shifts. However, many existing clinical prediction studies simplify inherently ordered outcomes into binary categories and rely on random data splits, limiting their relevance for real-world health system decision-making. In this study, we developed and evaluated an ordinal machine learning framework using clinical data from 5066 patients hospitalized with acute infectious diseases between 2022 and 2024. Recovery trajectories were modeled as an ordinal outcome, reflecting changes in status between admission and discharge. Models were trained on 2022–2023 data and externally evaluated on a fully isolated 2024 cohort to assess temporal generalizability under realistic deployment conditions. Performance was evaluated using order-aware metrics, including Quadratic Weighted Kappa, Macro-F1, Balanced Accuracy, and ordinal mean absolute error, with explicit analysis of clinically meaningful error structures. Although predictive performance under future holdout validation was modest, misclassifications were predominantly concentrated between adjacent recovery levels, and no clinically critical extreme errors were observed. Model reliability was further assessed through calibration analysis, bootstrap-based uncertainty estimation, and temporal stability of explanatory patterns. Finally, ordinal predictions were translated into structured risk stratification categories aligned with hospital bed management, treatment prioritization, and workforce allocation logic. These findings demonstrate the methodological potential of temporally validated ordinal modeling as a proof-of-concept framework. Given the modest predictive performance and the absence of key clinical variables, the current model should not be regarded as a ready-made clinical decision-support tool, but rather as a foundation for further development with richer data in future research. monitoring prioritization. In practical terms, this framework demonstrates how ordinal predictions could, in principle, be structured for use at admission points. However, given the modest predictive performance observed, further development with richer clinical data is required before deployment.

Public financial support can be rapidly disbursed yet remain unevaluable when fiscal, beneficiary, exposure, and outcome records are not linked. This study audits Mongolia’s livestock-sector support using budget-execution and livestock-loss data for 2010–2024, along with aggregated records for 289 classified White Gold concessional-loan applications as of 20 June 2025. The analysis distinguishes implementation, delivery conversion, concentration, spatial traceability, and the evidentiary requirements for causal effectiveness. Support execution rose from MNT 10.9 billion in 2010 to MNT 316.1 billion in 2024; the mean execution rate was 87.55% and the minimum 45.62%. Livestock mortality was episodic, with 10.2 million losses in 2010 and 9.3 million in 2024, but aggregate fiscal data cannot separate prevention, compensation, or anticipatory financing. Of the classified applications, 145 were approved and 133 disbursed; MNT 411.4 billion was recorded as disbursed, equal to 90.8% of the approved value and 47.2% of the requested value. Disbursement was concentrated in working capital (81.4%), cashmere-related purposes (80.9%), Ulaanbaatar-registered firms (95.0%), and five banks (94.7%; HHI = 0.246). The program is measurable for implementation and concentration, but not for final regional incidence or causal effectiveness. Evaluation-ready policy requires province-level exposure, supplier and beneficiary tracing, and post-finance outcomes.